Extracorporeal Membrane Oxygenation for the Support of Adults With Acute Myocarditis
Authors:
- Melvin C. AlmodovarMAMelvin C. Almodovar
- Satish K. RajagopalSRSatish K. Rajagopal
- Peter T. RycusPRPeter T. Rycus
- Ravi R. ThiagarajanRTRavi R. Thiagarajan
- 1 May 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 43 (5) , 1016-1025
Abstract
To characterize survival outcomes for adult patients with acute myocarditis supported with extracorporeal membrane oxygenation and identify risk factors for in-hospital mortality. Retrospective review of Extracorporeal Life Support Organization registry database. Data reported to Extracorporeal Life Support Organization by 230 extracorporeal membrane oxygenation centers. Patients 16 years old or older supported with extracorporeal membrane oxygenation for myocarditis during 1995 to 2011. None. There were 150 separate runs of extracorporeal membrane oxygenation for 147 patients with a diagnosis of acute myocarditis in the Extracorporeal Life Support Organization database from 1995 through 2011. Survival to hospital discharge was 61%. Nine patients underwent heart transplantation, and transplant-free survival to discharge was 56%. Extracorporeal membrane oxygenation was deployed during extracorporeal cardiopulmonary resuscitation in 31 patients (21% of the cohort). In a multivariate model evaluating pre-extracorporeal membrane oxygenation and extracorporeal membrane oxygenation support factors, pre-extracorporeal membrane oxygenation arrest (adjusted odds ratio, 2.4; 95% CI, 1.1-5.0) and need for higher extracorporeal membrane oxygenation flows at 4 hours post-extracorporeal membrane oxygenation cannulation (odds ratio, 2.8; 95% CI, 1.1-7.3) were associated with increased odds of in-hospital mortality. In a second multivariate model evaluating adverse events while on extracorporeal membrane oxygenation, central nervous system injury (odds ratio, 26.5; 95% CI, 7.3-96.6), renal failure (odds ratio, 3.6; 95% CI, 1.4-9.3), arrhythmia (odds ratio, 5.8; 95% CI, 2.2-15.1), and hyperbilirubinemia (odds ratio, 9.1; 95% CI, 2.6-31.8) were associated with increased odds of in-hospital mortality. Extracorporeal membrane oxygenation can be used effectively in adults with myocarditis to support the circulation while awaiting myocardial recovery. Early extracorporeal membrane oxygenation deployment prior to cardiac arrest may be associated with better outcomes.Keywords
This publication has 26 references indexed in Scilit:
- Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: A review of the Extracorporeal Life Support Organization registry*Critical Care Medicine, 2010
- Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trialThe Lancet, 2009
- Extracorporeal Membrane Oxygenation to Support Cardiopulmonary Resuscitation in AdultsThe Annals of Thoracic Surgery, 2009
- Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenationEuropean Heart Journal, 2005
- Long-Term Prognosis of Fulminant Myocarditis Rescued by Percutaneous Cardiopulmonary Support DeviceCirculation Journal, 2004
- Mechanical circulatory support for the treatment of children with acute fulminant myocarditisThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Long-Term Outcome of Fulminant Myocarditis as Compared with Acute (Nonfulminant) MyocarditisNew England Journal of Medicine, 2000
- Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapseThe American Journal of Cardiology, 1998
- Clinicopathoiogic description of myocarditisJACC, 1991
- Rescue of a patient with fulminant myocarditis by percutaneous extracorporeal bypass.Japanese Journal of Medicine, 1990